Picture of Melodiol Global Health logo

ME1 — Melodiol Global Health News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Creso Pharma Posts FY Unaudited Revenue Of A$9 Million, Up 44%

Jan 31 (Reuters) - Creso Pharma Ltd  CPH.AX :
    * FY2022 UNAUDITED REVENUE A$9 MILLION, UP 44%

Source text for Eikon:  ID:nASX114GZb 
Further company coverage:  CPH.AX 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Melodiol Global Health

See all news